日本的软体凝胶胶囊市场:各材料类型，各原料，各用途，各终端用户，各地区，机会，预测，2019年～2033年

日本软胶囊市场规模预计将从 2025 年的 4.9072 亿美元增长到 2033 年的 8.4314 亿美元，预测期内（2026-2033 年）的复合年增长率为 7%。市场成长的动力来自于老龄化社会的快速扩张、慢性病盛行率的上升以及医疗保健领域投资的增加。根据世界经济论坛估计，日本每十人就有一人年龄超过80岁。这种成长推动了市场扩张，增加了对各种药品的需求，以确保和维护民众的健康和福祉。

此外，软胶囊是膳食补充剂和药物的首选输送系统，因为它们具有更高的生物利用度和易于摄取的特点，使其成为管理慢性疾病和维持营养需求的理想选择。另一方面，日本医疗保健基础设施的扩张和个人化医疗意识的增强也促进了市场的成长。

此外，软胶囊製造技术的进步，例如生产不含角叉菜和植物性配方，进一步满足了注重健康的消费者寻求天然和可持续产品的偏好。个人化医疗意识的提高和日本强大的医疗保健基础设施是支持日本市场成长的其他关键因素。

本报告提供日本的软体凝胶胶囊市场相关调查，提供市场概要，以及各材料类型，各原料，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 日本的软体凝胶胶囊市场预测，2019年～2033年

• 市场规模分析与预测
• 市场占有率分析与预测
• 2025年市场地图分析
  • 各材料类型
  • 各原料
  • 各用途
  • 各终端用户
  • 各地区

第5章 需求供给分析

第6章 价值链分析

第7章 波特的五力分析

第8章 大环境分析

第9章 价格分析

第10章 市场动态

• 市场促进因素
• 市场课题

第11章 市场趋势与发展

第12章 法规情形

第13章 案例研究

第14章 竞争情形

• 前五名市场领导的竞争矩阵
• 前五名参与企业的SWOT分析
• 前10名市场主要企业的形势
  • Gelita AG
  • Darling Ingredients Inc.
  • Nitta Gelatin, Inc.
  • Tessenderlo Group
  • Soft Gel Technologies, Inc.
  • Gelatin, Inc.
  • Narmada Gelatines Limited
  • Xiamen Gelken Gelatin Co., Ltd.
  • Aenova Group
  • Sirio Pharma Co., Ltd.
  • Catalent, Inc.

第15章 策略性建议

第16章 关于调查公司·免责声明

Japan softgel capsules market is projected to witness a CAGR of 7% during the forecast period FY2026-FY2033, growing from USD 490.72 million in FY2025 to USD 843.14 million in FY2033. The market's growth is supported by the rapid expansion of the aging population, rising prevalence of chronic diseases, and increasing investments in the healthcare sector. According to the estimates of the World Economic Forum, over one in ten people are 80 or older in Japan. This growth is augmenting the requirement for various pharmaceutical products and medications to ensure and maintain the health and well-being of the population, supporting the market's expansion.

Moreover, softgel capsules are the preferred delivery system for nutritional supplements and medications as they offer enhanced bioavailability and ease of consumption, making them ideal for managing chronic conditions and maintaining nutritional requirements. Meanwhile, the expanding healthcare infrastructure and rising awareness about personalized medicines in Japan also contribute to the market's growth as different pharmaceutical companies are actively investing in research and development activities to introduce innovative formulations that are tailored to the requirements of the patient population.

Additionally, technological advancements in manufacturing softgel capsules, including production of carrageenan-free and plant-based formulations are further catering to the preferences of the health-conscious consumers seeking natural and sustainable products. Growing awareness about personalized medicines coupled with the country's robust healthcare infrastructure are other major factors sustaining the market's growth in Japan.

Aging Population Supports Market Expansion

As individuals age, they often experience difficulties swallowing tablets due to conditions such as dry mouth or reduced swallowing ability. Softgel capsules due to their gelatinous coating are smooth in nature and provide a convenient and easy-to-swallow alternative for the older population. As per the estimates of the National Institute of Population and Social Security Research, approximately 34.8% of the population will be 65 or older by 2040.

Thus, softgel capsules are widely used in the country for delivering medications and nutritional supplements that help in managing chronic conditions. The enhanced bioavailability of softgel capsules ensures effective absorption of active ingredients, critical for elderly patients that may have compromised digestive systems.

Increasing Emphasis on Health and Wellness Boosts Market Demand

The rising emphasis on health and wellness is Japan due to increasing prevalence of various chronic diseases is augmenting the requirement for different pharmaceutical and nutraceutical products. As per the estimates of an article published in the Journal of Cardiology in March 2024, approximately 310,000 people die from cardiovascular diseases in Japan every year.

The country's population is actively seeking dietary supplements and nutraceuticals for maintaining their overall health and wellbeing and preventing chronic diseases. Additionally, compared to other tablets and powders, softgel capsules offer better stability for reactive ingredients. Meanwhile, functional foods and beverages are also gaining traction in the country. Several of such products use softgels for incorporating their active ingredients to enhance efficacy and maintain potency, further supporting the market's expansion.

Gelatin-based Capsules Account for Significant Share of the Market

The popularity of gelatin-based capsules stems from their ability to encapsulate both liquid and semi-liquid formulations while ensuring enhanced bioavailability and stability of active ingredients. The strong gelatin market in Japan supports this trend, with bovine-sourced gelatin being the largest segment due to its perceived benefits like skin rejuvenation and bone strengthening. Additionally, gelatin's compatibility with pharmaceutical and nutraceutical applications makes it a preferred material for softgel manufacturing. Moreover, its affordability compared to non-animal-based alternatives further contributes to the segment's dominance. As demand for softgel capsules continues to increase in the country, gelatin-based capsules are expected to maintain their position in the market.

Nutraceutical Companies Hold Major Market Share

Due to the increasing health consciousness among the general population and rapid expansion of the aging population, the requirement for nutraceuticals is significantly increasing, bolstering the demand for softgel capsules among nutraceutical companies. In order to maintain their competitive edge and expand their presence, these companies are also focusing on launching new products. For instance, in May 2024, Natural Technology Co., Ltd. launched a new product called Eyepa, an all-in-one supplement for targeting various eye problems including eye strain and dry eyes, among others. The product contains ingredients including, astaxanthin, zeaxanthin, vitamins A, C, and E, pentadecyl, raspberry, zinc, bilberry, Megusurino tree extract, and lutein.

Future Market Scenario (FY2026 - FY2033F)

The market is expected to encounter strong expansion opportunities in the coming years due to the rapid expansion of the pharmaceutical and nutraceutical industries, innovations in softgel capsule technologies, growth of the aging population, and novel product launches. Advanced encapsulation technologies are going to provide higher stability, sustained release mechanism, and targeted delivery of the drug.

Additionally, the market's growth is also supported by increasing investments in local manufacturing to reduce dependency on imports and in research and development of functional and plant-based softgel formulations. Moreover, the integration of plant-based softgel technologies is expected to support the market's expansion, allowing leading players of the market to cater to the preferences of the vegetarian population.

Key Players Landscape and Outlook

The key players of the market are actively investing in expansion of their facilities in Japan, providing lucrative growth opportunities for the market. For instance, in May 2023, Catalent, Inc. expanded its facility in Shiga, Japan to include state-of-the-art cryogenic freezers and material transfer equipment designed to maintain the integrity of advanced therapy products by minimizing their time out of a controlled environment. This move is part of the company's strategy to enhance its ability to handle, store, and manage advanced therapies for clinical supply across the country as well as globally.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Softgel Capsules Market Outlook, FY2019-FY2033F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Material Type
    • 4.2.1.1. Gelatin/Animal-based
    • 4.2.1.2. Non- Animal-based
  • 4.2.2. By Source
    • 4.2.2.1. Porcine
    • 4.2.2.2. Bovine
    • 4.2.2.3. Others
  • 4.2.3. By Application
    • 4.2.3.1. Antacid and Anti-flatulent Preparations
    • 4.2.3.2. Anti-anemic Preparations
    • 4.2.3.3. Anti-inflammatory Drugs
    • 4.2.3.4. Antibiotic and Antibacterial Drugs
    • 4.2.3.5. Cough and Cold Preparations
    • 4.2.3.6. Health Supplements
    • 4.2.3.7. Vitamin and Dietary Supplements
  • 4.2.4. By End-user
    • 4.2.4.1. Pharmaceutical Companies
    • 4.2.4.2. Nutraceutical Companies
    • 4.2.4.3. Cosmeceutical Companies
    • 4.2.4.4. Contract Manufacturing Organizations
  • 4.2.5. By Region
    • 4.2.5.1. North [Hokkaido and Tohoku]
    • 4.2.5.2. Central [Kanto and Chubu]
    • 4.2.5.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
• 4.3. Market Map Analysis, FY2025
  • 4.3.1. By Material Type
  • 4.3.2. By Source
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Landscape

13. Case Studies

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Gelita AG
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. Darling Ingredients Inc.
  • 14.3.3. Nitta Gelatin, Inc.
  • 14.3.4. Tessenderlo Group
  • 14.3.5. Soft Gel Technologies, Inc.
  • 14.3.6. Gelatin, Inc.
  • 14.3.7. Narmada Gelatines Limited
  • 14.3.8. Xiamen Gelken Gelatin Co., Ltd.
  • 14.3.9. Aenova Group
  • 14.3.10. Sirio Pharma Co., Ltd.
  • 14.3.11. Catalent, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Softgel Capsules Market, By Value, In USD Million, FY2019-FY2033F
• Figure 2. Japan Softgel Capsules Market Share (%), By Material Type, FY2019-FY2033F
• Figure 3. Japan Softgel Capsules Market Share (%), By Source, FY2019-FY2033F
• Figure 4. Japan Softgel Capsules Market Share (%), By Application, FY2019-FY2033F
• Figure 5. Japan Softgel Capsules Market Share (%), By End-user, FY2019-FY2033F
• Figure 6. Japan Softgel Capsules Market Share (%), By Region, FY2019-FY2033F
• Figure 7. By Material Type Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 8. By Source Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 10. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 11. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2025